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In thIs Issue iceman genome available for browsing
The recent whole-genome sequencing of the 5,300-year-old Iceman Ötzi, found in 1991 in the Italian Alps, provides not only insights into his health and genetic relationship to modern Europeans but also a public resource for further genomic study. A sliver of hipbone provided the DNA, which was extracted at the Institute of Human Genetics in Tübingen, Germany. Next-generation technology allowed for sequence reads of nearly 96% of the reference human genome, with fivefold coverage for most of the sequence. Analysis revealed that the modern-day population to which Ötzi is genetically most similar is the geographically isolated population inhabiting the Italian island Sardinia and that he is genetically distant from modern mainland Europeans. Ötzi's Y-haplogroup, G2a4, has been found at high frequency only in the Mediterranean islands of Sardinia and Corsica. Genomic analysis revealed that he was probably brown-eyed, had type O+ blood, and, like nearly all early-neolithic humans, was lactose intolerant. He carried three single-nucleotide polymorphism (SNP)-associated risk factors for coronary artery disease and atherosclerosis, which might help explain why computed-tomography scans showed atherosclerotic plaque in several major arteries despite a presumably active lifestyle. Additional sequencing turned up 60% of the genome of the pathogen Borrelia burgdorferi, the causative agent of Lyme disease in humans. Now the Iceman's genome is available for further study at http://IcemanGenome.net. The site contains all the aligned sequencing reads to the Human Genome Reference 19 and provides some gene identification, SNP annotation, insertions, and deletions. 
mapping dispensable dnA
Locating genomic sequences essential for human development, particularly noncoding segments, remains a challenge for genomic research. The relative importance of copy number variants (CNVs), including non-genic segments, is still a matter of debate. For example, the tolerability of hemizygous states raises the question of whether the nullizygous state is also nonpathogenic. To address such questions, a team from Saudi Arabia studied the full set of autozygous intervals-the "autozygome"-of the offspring of firstcousin unions, which are relatively common in Saudi culture. By comparing the observed distribution with the expected Mendelian 25:50:25 ratio (nullizygous:hemizygous:wild type), the team found a highly significant bias against nullizygosity in a subset of CNVs. The results provide possible evidence that the human genome is biased against nullizygosity in some regions where hemizygosity is apparently tolerated. Furthermore, when compared with unbiased DNA segments, the 24 hemizygous DNA segments that were biased against nullizygosity also showed less frequent sequence variation in the normal population. Half of these regions were noncoding, raising the possibility of a conserved regulatory function for this non-genic DNA in human development. This small, proof-of-principle study raises the interesting possibility of using the autozygome as a tool for mapping dispensable regions of human DNA and may ultimately inform clinical interpretation of array and sequencing analysis.
Web-based prompts enhance communication in initial breast cancer genetic counseling
Use of a Web-based precounseling question prompt sheet (QPS) enhances the quality and personalization of the subsequent visit in an initial breast cancer genetic screening, according to a study conducted in the Netherlands. The QPS provides basic information and allows patients to present their questions before a consultation. Similar studies with a QPS provided before counseling had shown promise in engaging patients in the oncology setting, but those studies did not include observation of the counseling session. In this first randomized, controlled trial, 192 initial counseling sessions were videotaped to provide coded, unbiased feedback on the number of questions counselees asked and the quality of engagement during the counseling session. The results showed that the QPS did not increase the number of questions asked, but participants who filled out the sheet took a more active role during the visit, talking more often about their reasons for concern, their prior knowledge of hereditary breast cancer, and their perception of their own risk. In addition, counselors provided more tailored information and more frequently discussed the need for DNA testing, with no difference in the duration of the visit. News Briefs ments (CMM), a rare disorder in which voluntary movement on one side of the body is involuntarily mirrored on the opposite side. The study demonstrates the utility of whole-exome analysis in pinpointing gene variants in simple Mendelian disorders. The investigators studied two extended families with the autosomal dominant disorder. Surprisingly, affected individuals in both families had heterozygous mutations introducing premature stop codons in RAD51, a double-stranded break repair protein known to be involved in cancer. RAD51 mRNA was significantly downregulated in individuals with CMM as a result of degradation of mutated mRNA. Supplementary studies in mice located RAD51 in the corticospinal axons of developing mice. The finding suggests that RAD51 plays a role in early development of the nervous system and provides a new line of investigation for researchers seeking to understand the development of motor control in humans.
A call to trainees! submit your research to GIM! the Annual Richard King trainee Award for Best Publication
In order to encourage genetics trainees in their professional development, Genetics in Medicine and The American College of Medical Genetics Foundation have an annual award recognizing an outstanding research publication by an ABMG trainee. The award consists of a $1,000 cash prize to the recipient as well as travel, hotel and registration costs for the annual ACMG meeting that year. Eligible individuals are ABMG trainees who have been first author or corresponding author on a paper published the preceding calendar year in Genetics in Medicine.
Eligible trainees include those in the following programs:
Medical Genetics (MDs) Combined Internal Medicine/Genetics Combined Pediatrics/Genetics Combined OBGYN/Genetics Clinical Biochemical Genetics Clinical Cytogenetics Clinical Molecular Genetics Subspecialty-Medical Biochemical Genetics Subspecialty-Molecular Genetic Pathology Eligible trainees should identify themselves upon submission of manuscripts to Genetics in Medicine. Original research, brief reports and educational reports are eligible categories, but other categories, such as review articles, are not. The editorial board of Genetics in Medicine will determine the winning trainee and presentation of the award will be made each year at the American College of Medical Genetics Annual Meeting.
